ReP USP - Resultado da busca

Artigo de periodico
The Ala134Thr variant in TMEM176B exerts a beneficial role in colorectal cancer prognosis by increasing NLRP3 inflammasome activation (2022)
Cambui, Raylane Adrielle Gonçalves ; Fernandes, Fernanda Pereira; Leal, Vinicius Nunes Cordeiro ; Reis, Edione Cristina dos ; Lima, Dhemerson Souza de ; Santo, Gilmar Ferreira do Espírito ; Elias, Rosa Maria ; Pontillo, Alessandra
Source: Journal of Cancer Research and Clinical Oncology. Unidade: ICB
Subjects: IMUNOLOGIA, CAMUNDONGOS, MODELOS ANIMAIS DE DOENÇAS, CÉLULAS CULTIVADAS DE TUMOR, VARIAÇÃO GENÉTICA, COMPLEXOS MULTIENZIMÁTICOS, NUCLEOTÍDEOS, NEOPLASIAS DO COLON, ESTUDOS DE COORTES, GENÓTIPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMBUI, Raylane Adrielle Gonçalves et al. The Ala134Thr variant in TMEM176B exerts a beneficial role in colorectal cancer prognosis by increasing NLRP3 inflammasome activation. Journal of Cancer Research and Clinical Oncology, p. 1-10, 2022Tradução . . Disponível em: https://doi.org/10.1007/s00432-022-04284-8. Acesso em: 26 out. 2025.
APA
Cambui, R. A. G., Fernandes, F. P., Leal, V. N. C., Reis, E. C. dos, Lima, D. S. de, Santo, G. F. do E., et al. (2022). The Ala134Thr variant in TMEM176B exerts a beneficial role in colorectal cancer prognosis by increasing NLRP3 inflammasome activation. Journal of Cancer Research and Clinical Oncology, 1-10. doi:10.1007/s00432-022-04284-8
NLM
Cambui RAG, Fernandes FP, Leal VNC, Reis EC dos, Lima DS de, Santo GF do E, Elias RM, Pontillo A. The Ala134Thr variant in TMEM176B exerts a beneficial role in colorectal cancer prognosis by increasing NLRP3 inflammasome activation [Internet]. Journal of Cancer Research and Clinical Oncology. 2022 ; 1-10.[citado 2025 out. 26 ] Available from: https://doi.org/10.1007/s00432-022-04284-8
Vancouver
Cambui RAG, Fernandes FP, Leal VNC, Reis EC dos, Lima DS de, Santo GF do E, Elias RM, Pontillo A. The Ala134Thr variant in TMEM176B exerts a beneficial role in colorectal cancer prognosis by increasing NLRP3 inflammasome activation [Internet]. Journal of Cancer Research and Clinical Oncology. 2022 ; 1-10.[citado 2025 out. 26 ] Available from: https://doi.org/10.1007/s00432-022-04284-8
Artigo de periodico
The role of metformin on lung cancer survival: the first systematic review and meta-analysis of observational studies and randomized clinical trials (2021)
Brancher, Suzan ; Ribeiro, Ana Elisa; Toporcov, Tatiana Natasha ; Weiderpass, Elisabete
Source: Journal of Cancer Research and Clinical Oncology. Unidade: FSP
Subjects: NEOPLASIAS PULMONARES, METFORMINA, REVISÃO SISTEMÁTICA, ESTUDOS RANDOMIZADOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRANCHER, Suzan et al. The role of metformin on lung cancer survival: the first systematic review and meta-analysis of observational studies and randomized clinical trials. Journal of Cancer Research and Clinical Oncology, v. 147, p. 2819-2836, 2021Tradução . . Disponível em: https://doi.org/10.1007/s00432-021-03728-x. Acesso em: 26 out. 2025.
APA
Brancher, S., Ribeiro, A. E., Toporcov, T. N., & Weiderpass, E. (2021). The role of metformin on lung cancer survival: the first systematic review and meta-analysis of observational studies and randomized clinical trials. Journal of Cancer Research and Clinical Oncology, 147, 2819-2836. doi:10.1007/s00432-021-03728-x
NLM
Brancher S, Ribeiro AE, Toporcov TN, Weiderpass E. The role of metformin on lung cancer survival: the first systematic review and meta-analysis of observational studies and randomized clinical trials [Internet]. Journal of Cancer Research and Clinical Oncology. 2021 ;147 2819-2836.[citado 2025 out. 26 ] Available from: https://doi.org/10.1007/s00432-021-03728-x
Vancouver
Brancher S, Ribeiro AE, Toporcov TN, Weiderpass E. The role of metformin on lung cancer survival: the first systematic review and meta-analysis of observational studies and randomized clinical trials [Internet]. Journal of Cancer Research and Clinical Oncology. 2021 ;147 2819-2836.[citado 2025 out. 26 ] Available from: https://doi.org/10.1007/s00432-021-03728-x
Artigo de periodico
Inhibition of Aurora Kinases enhances chemosensitivity to temozolomide and causes radiosensitization in glioblastoma cells (2012)
Borges, Kleiton Silva; Gamero, Angel Mauricio Castro; Moreno, Daniel Antunes; Silveira, Vanessa da Silva; Brassesco, Maria Sol; Queiroz, Rosane Gomes de Paula; Oliveira, Harley Francisco de; Carlotti Júnior, Carlos Gilberto; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga
Source: Journal of Cancer Research and Clinical Oncology. Unidade: FMRP
Subjects: NEOPLASIAS CEREBRAIS, PROTEÍNAS QUINASES, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGES, Kleiton Silva et al. Inhibition of Aurora Kinases enhances chemosensitivity to temozolomide and causes radiosensitization in glioblastoma cells. Journal of Cancer Research and Clinical Oncology, v. 138, n. 3, p. 405-414, 2012Tradução . . Disponível em: https://doi.org/10.1007/s00432-011-1111-0. Acesso em: 26 out. 2025.
APA
Borges, K. S., Gamero, A. M. C., Moreno, D. A., Silveira, V. da S., Brassesco, M. S., Queiroz, R. G. de P., et al. (2012). Inhibition of Aurora Kinases enhances chemosensitivity to temozolomide and causes radiosensitization in glioblastoma cells. Journal of Cancer Research and Clinical Oncology, 138( 3), 405-414. doi:10.1007/s00432-011-1111-0
NLM
Borges KS, Gamero AMC, Moreno DA, Silveira V da S, Brassesco MS, Queiroz RG de P, Oliveira HF de, Carlotti Júnior CG, Scrideli CA, Tone LG. Inhibition of Aurora Kinases enhances chemosensitivity to temozolomide and causes radiosensitization in glioblastoma cells [Internet]. Journal of Cancer Research and Clinical Oncology. 2012 ; 138( 3): 405-414.[citado 2025 out. 26 ] Available from: https://doi.org/10.1007/s00432-011-1111-0
Vancouver
Borges KS, Gamero AMC, Moreno DA, Silveira V da S, Brassesco MS, Queiroz RG de P, Oliveira HF de, Carlotti Júnior CG, Scrideli CA, Tone LG. Inhibition of Aurora Kinases enhances chemosensitivity to temozolomide and causes radiosensitization in glioblastoma cells [Internet]. Journal of Cancer Research and Clinical Oncology. 2012 ; 138( 3): 405-414.[citado 2025 out. 26 ] Available from: https://doi.org/10.1007/s00432-011-1111-0
Artigo de periodico
Short-term anastrozole therapy reduces Ki-67 and progesterone receptor expression in invasive breast cancer: a prospective, placebo-controlled, double-blind trial (2011)
Mattar, Andre; Logullo, Angela Flávia; Facina, Gil; Nonogaki, Suely; Soares, Fernando Augusto; Gebrim, Luiz Henrique
Source: Journal of Cancer Research and Clinical Oncology. Unidade: FO
Subjects: NEOPLASIAS BUCAIS, NEOPLASIAS, HORMÔNIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MATTAR, Andre et al. Short-term anastrozole therapy reduces Ki-67 and progesterone receptor expression in invasive breast cancer: a prospective, placebo-controlled, double-blind trial. Journal of Cancer Research and Clinical Oncology, v. 137, n. 5, p. 897-905, 2011Tradução . . Disponível em: https://doi.org/10.1007/s00432-010-0950-4. Acesso em: 26 out. 2025.
APA
Mattar, A., Logullo, A. F., Facina, G., Nonogaki, S., Soares, F. A., & Gebrim, L. H. (2011). Short-term anastrozole therapy reduces Ki-67 and progesterone receptor expression in invasive breast cancer: a prospective, placebo-controlled, double-blind trial. Journal of Cancer Research and Clinical Oncology, 137( 5), 897-905. doi:10.1007/s00432-010-0950-4
NLM
Mattar A, Logullo AF, Facina G, Nonogaki S, Soares FA, Gebrim LH. Short-term anastrozole therapy reduces Ki-67 and progesterone receptor expression in invasive breast cancer: a prospective, placebo-controlled, double-blind trial [Internet]. Journal of Cancer Research and Clinical Oncology. 2011 ; 137( 5): 897-905.[citado 2025 out. 26 ] Available from: https://doi.org/10.1007/s00432-010-0950-4
Vancouver
Mattar A, Logullo AF, Facina G, Nonogaki S, Soares FA, Gebrim LH. Short-term anastrozole therapy reduces Ki-67 and progesterone receptor expression in invasive breast cancer: a prospective, placebo-controlled, double-blind trial [Internet]. Journal of Cancer Research and Clinical Oncology. 2011 ; 137( 5): 897-905.[citado 2025 out. 26 ] Available from: https://doi.org/10.1007/s00432-010-0950-4
Artigo de periodico
International symposium on new leads in experimental and clinical gene targeting in cancer (2003)
Zanker, K. S.; Brentani, R.; Mihich, E.
Source: Journal of Cancer Research and Clinical Oncology. Unidade: FM
Subjects: GENES, CONFERÊNCIA INTERNACIONAL, NEOPLASIAS (GENÉTICA), GENOMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZANKER, K. S. e BRENTANI, R. e MIHICH, E. International symposium on new leads in experimental and clinical gene targeting in cancer. Journal of Cancer Research and Clinical Oncology, v. 129, p. 258-261, 2003Tradução . . Acesso em: 26 out. 2025.
APA
Zanker, K. S., Brentani, R., & Mihich, E. (2003). International symposium on new leads in experimental and clinical gene targeting in cancer. Journal of Cancer Research and Clinical Oncology, 129, 258-261.
NLM
Zanker KS, Brentani R, Mihich E. International symposium on new leads in experimental and clinical gene targeting in cancer. Journal of Cancer Research and Clinical Oncology. 2003 ; 129 258-261.[citado 2025 out. 26 ]
Vancouver
Zanker KS, Brentani R, Mihich E. International symposium on new leads in experimental and clinical gene targeting in cancer. Journal of Cancer Research and Clinical Oncology. 2003 ; 129 258-261.[citado 2025 out. 26 ]
Trabalho de evento-resumo periodico
Aerobic capacity and muscle strength in malnourished cancer patients (1990)
Leme, R B A; Dias, M. C. G.; Battaglia, C; Libanori, H T; Maluf, F; Faintuch, B L; Faintuch, Joel; Pinotti, Henrique Walter
Source: Journal of Cancer Research and Clinical Oncology. Conference titles: International Cancer Congress. Unidade: FM
Assunto: ONCOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEME, R B A et al. Aerobic capacity and muscle strength in malnourished cancer patients. Journal of Cancer Research and Clinical Oncology. [S.l.]: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 26 out. 2025. , 1990
APA
Leme, R. B. A., Dias, M. C. G., Battaglia, C., Libanori, H. T., Maluf, F., Faintuch, B. L., et al. (1990). Aerobic capacity and muscle strength in malnourished cancer patients. Journal of Cancer Research and Clinical Oncology. Faculdade de Medicina, Universidade de São Paulo.
NLM
Leme RBA, Dias MCG, Battaglia C, Libanori HT, Maluf F, Faintuch BL, Faintuch J, Pinotti HW. Aerobic capacity and muscle strength in malnourished cancer patients. Journal of Cancer Research and Clinical Oncology. 1990 ;116( supl. pt.1): 642.[citado 2025 out. 26 ]
Vancouver
Leme RBA, Dias MCG, Battaglia C, Libanori HT, Maluf F, Faintuch BL, Faintuch J, Pinotti HW. Aerobic capacity and muscle strength in malnourished cancer patients. Journal of Cancer Research and Clinical Oncology. 1990 ;116( supl. pt.1): 642.[citado 2025 out. 26 ]
Trabalho de evento-resumo periodico
Modified parenteral nutrition in weight-losing cancer patients (1990)
Faintuch, B L; Faintuch, Joel; Ribeiro Junior, U; Gama Rodrigues, Joaquim José; Pinotti, Henrique Walter
Source: Journal of Cancer Research and Clinical Oncology. Conference titles: International Cancer Congress. Unidade: FM
Assunto: NUTRIÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FAINTUCH, B L et al. Modified parenteral nutrition in weight-losing cancer patients. Journal of Cancer Research and Clinical Oncology. [S.l.]: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 26 out. 2025. , 1990
APA
Faintuch, B. L., Faintuch, J., Ribeiro Junior, U., Gama Rodrigues, J. J., & Pinotti, H. W. (1990). Modified parenteral nutrition in weight-losing cancer patients. Journal of Cancer Research and Clinical Oncology. Faculdade de Medicina, Universidade de São Paulo.
NLM
Faintuch BL, Faintuch J, Ribeiro Junior U, Gama Rodrigues JJ, Pinotti HW. Modified parenteral nutrition in weight-losing cancer patients. Journal of Cancer Research and Clinical Oncology. 1990 ;116( supl. pt.1): 642.[citado 2025 out. 26 ]
Vancouver
Faintuch BL, Faintuch J, Ribeiro Junior U, Gama Rodrigues JJ, Pinotti HW. Modified parenteral nutrition in weight-losing cancer patients. Journal of Cancer Research and Clinical Oncology. 1990 ;116( supl. pt.1): 642.[citado 2025 out. 26 ]
Artigo de periodico
Qualitative erythrocyte enzymatic disorder in ehrlich tumor-baaring in mice (1985)
Barretto, Orlando César de Oliveira; Zyngier, Szulim Ber
Source: Journal of Cancer Research and Clinical Oncology. Unidades: ICB, FM
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARRETTO, Orlando César de Oliveira e ZYNGIER, Szulim Ber. Qualitative erythrocyte enzymatic disorder in ehrlich tumor-baaring in mice. Journal of Cancer Research and Clinical Oncology, v. 110, p. 247-248, 1985Tradução . . Disponível em: https://doi.org/10.1007/bf00399283. Acesso em: 26 out. 2025.
APA
Barretto, O. C. de O., & Zyngier, S. B. (1985). Qualitative erythrocyte enzymatic disorder in ehrlich tumor-baaring in mice. Journal of Cancer Research and Clinical Oncology, 110, 247-248. doi:10.1007/bf00399283
NLM
Barretto OC de O, Zyngier SB. Qualitative erythrocyte enzymatic disorder in ehrlich tumor-baaring in mice [Internet]. Journal of Cancer Research and Clinical Oncology. 1985 ; 110 247-248.[citado 2025 out. 26 ] Available from: https://doi.org/10.1007/bf00399283
Vancouver
Barretto OC de O, Zyngier SB. Qualitative erythrocyte enzymatic disorder in ehrlich tumor-baaring in mice [Internet]. Journal of Cancer Research and Clinical Oncology. 1985 ; 110 247-248.[citado 2025 out. 26 ] Available from: https://doi.org/10.1007/bf00399283

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Date published

Subjects

Indexado em

Non normalized affiliation